Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. 1986.
Kärre
Klas
K
Ljunggren
Hans Gustaf
HG
Piontek
Gerald
G
Kiessling
Rolf
R
D000818:Animals; D045744:Cell Line, Tumor; D003602:Cytotoxicity, Immunologic / Q000235:genetics; D006084:Graft Rejection / Q000235:genetics / Q000266:history* / Q000276:immunology; D006183:H-2 Antigens / Q000235:genetics / Q000266:history*; D049673:History, 20th Century; D007113:Immunity, Innate / Q000235:genetics; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D016399:Lymphoma, T-Cell / Q000235:genetics / Q000266:history* / Q000276:immunology*; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation / Q000266:history
D006183:H-2 Antigens